California Official Touts Benefits of ePedigree for OTC Drugmakers

August 15, 2013
While OTC drugmakers aren’t required to serialize their products under California’s electronic pedigree law, voluntary participation could benefit patient safety, officials charged with implementing the law say. By January 2015, drugmakers must serialize 50 percent of their total product entering California’s market.
Drug Industry Daily